慢性髓性白血病中RT-qPCR检测BCR-ABL1:国际外部质量评估项目的结果
该研究回顾了UK NEQAS白细胞免疫表型检测项目2007至2015年的外部质量评估数据,评估技术标准化和国际标准(IS)对BCR-ABL1检测准确性的影响。参与者结果在高疾病水平和低疾病水平(包括治疗关键决策点)均存在相当大的变异性;转换为IS的结果比未转换数据集的变异性更小。不同IS转换方法在UKNEQAS LI的IS数据集中产生一致不同的中位结果。
要点
- 高、低疾病水平(含治疗关键决策点)的参与者结果均存在相当大的变异性。
- 转换为IS的结果比未转换数据集的变异性更小。
- 不同IS转换方法在UKNEQAS LI的IS数据集中产生一致不同的中位结果。
核心结论
- IS的发展改善了中心间结果的可比性,但仍需进一步改进将原始结果转换为IS的流程,以充分实现CML分子监测的获益。
研究设计与样本
- 回顾UK NEQAS白细胞免疫表型检测(UKNEQAS LI)2007年至2015年的外部质量评估(EQA)试验数据。
主要发现
- 参与者结果在高疾病水平和低疾病水平(包括治疗关键决策点)均存在相当大的变异性。
- 转换为IS的结果与未转换数据集相比变异性更小。
- 不同IS转换方法在UKNEQAS LI的IS数据集中产生一致不同的中位结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sequential measurement of BCR-ABL1 mRNA levels by reverse transcription quantitative polymerase chain reaction (RT-qPCR) is embedded in the management of patients with chronic myeloid leukaemia (CML), and has played an important role in the remarkable improvement in patient outcomes seen in this disease. As a provider of external quality assessment (EQA) in this area, UK NEQAS for Leucocyte Immunophenotyping (UKNEQAS LI) has a unique perspective on the changing face of BCR-ABL1 testing in CML. To assess the impact of technical standardisation and the development of the International Scale (IS) upon the accuracy of BCR-ABL1 testing, we reviewed EQA trial data from 2007 to 2015. Comparison of participant results identified considerable variability at both high and low levels of disease, including therapeutically important decision points; however, results converted to the IS showed less variability compared to unconverted data sets. We also found that different methods of converting to the IS produce consistently different median results within UKNEQAS LI IS data sets. This data suggests that whilst the development of the IS has improved the comparability of results between centres, there is still the need for further improvement in the processes of converting raw results to the IS in order to fully realise the benefits of molecular monitoring of CML.
引用
- Scott S, Travis D, Whitby L, et al. Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme. Br J Haematol. 2017. PMID: 28295199. doi:10.1111/bjh.14557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。